patents.google.com

CN108795864A - A method of obtaining the class retinal tissue rich in the cone and rod cell using people's induced multi-potent stem cell - Google Patents

  • ️Tue Nov 13 2018
A method of obtaining the class retinal tissue rich in the cone and rod cell using people's induced multi-potent stem cell Download PDF

Info

Publication number
CN108795864A
CN108795864A CN201810510145.4A CN201810510145A CN108795864A CN 108795864 A CN108795864 A CN 108795864A CN 201810510145 A CN201810510145 A CN 201810510145A CN 108795864 A CN108795864 A CN 108795864A Authority
CN
China
Prior art keywords
cell
culture
cone
retinal
hipscs
Prior art date
2018-05-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810510145.4A
Other languages
Chinese (zh)
Other versions
CN108795864B (en
Inventor
钟秀风
李桂兰
谢冰冰
彭福华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Hongchang Biotechnology Co Ltd
Zhongshan Ophthalmic Center
Original Assignee
Guangzhou Hongchang Biotechnology Co Ltd
Zhongshan Ophthalmic Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
2018-05-24
Filing date
2018-05-24
Publication date
2018-11-13
2018-05-24 Application filed by Guangzhou Hongchang Biotechnology Co Ltd, Zhongshan Ophthalmic Center filed Critical Guangzhou Hongchang Biotechnology Co Ltd
2018-05-24 Priority to CN201810510145.4A priority Critical patent/CN108795864B/en
2018-11-13 Publication of CN108795864A publication Critical patent/CN108795864A/en
2021-08-24 Application granted granted Critical
2021-08-24 Publication of CN108795864B publication Critical patent/CN108795864B/en
Status Expired - Fee Related legal-status Critical Current
2038-05-24 Anticipated expiration legal-status Critical

Links

  • 210000004027 cell Anatomy 0.000 title claims abstract description 101
  • 230000002207 retinal effect Effects 0.000 title claims abstract description 51
  • 238000000034 method Methods 0.000 title claims abstract description 22
  • 210000002894 multi-fate stem cell Anatomy 0.000 title claims abstract description 7
  • 210000001525 retina Anatomy 0.000 claims abstract description 52
  • 230000004069 differentiation Effects 0.000 claims abstract description 23
  • 230000006698 induction Effects 0.000 claims abstract description 22
  • 238000001556 precipitation Methods 0.000 claims abstract description 19
  • 210000005157 neural retina Anatomy 0.000 claims abstract description 13
  • SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims abstract description 11
  • 229930002330 retinoic acid Natural products 0.000 claims abstract description 11
  • 229960001727 tretinoin Drugs 0.000 claims abstract description 11
  • 102000010175 Opsin Human genes 0.000 claims abstract description 10
  • 108050001704 Opsin Proteins 0.000 claims abstract description 10
  • NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 claims abstract description 9
  • 102000004330 Rhodopsin Human genes 0.000 claims abstract description 9
  • 108090000820 Rhodopsin Proteins 0.000 claims abstract description 9
  • 210000002242 embryoid body Anatomy 0.000 claims abstract description 9
  • 108010082117 matrigel Proteins 0.000 claims abstract description 8
  • 210000001519 tissue Anatomy 0.000 claims description 44
  • KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 42
  • 230000029087 digestion Effects 0.000 claims description 36
  • 210000003583 retinal pigment epithelium Anatomy 0.000 claims 4
  • 230000035807 sensation Effects 0.000 claims 1
  • 210000000608 photoreceptor cell Anatomy 0.000 abstract description 13
  • 239000007788 liquid Substances 0.000 abstract description 7
  • 238000005457 optimization Methods 0.000 abstract description 6
  • 108010007093 dispase Proteins 0.000 description 29
  • 238000011161 development Methods 0.000 description 12
  • 230000018109 developmental process Effects 0.000 description 12
  • 239000004615 ingredient Substances 0.000 description 10
  • 230000007774 longterm Effects 0.000 description 9
  • 238000002360 preparation method Methods 0.000 description 7
  • 230000000694 effects Effects 0.000 description 6
  • 230000001939 inductive effect Effects 0.000 description 6
  • 108091008695 photoreceptors Proteins 0.000 description 6
  • 238000001179 sorption measurement Methods 0.000 description 6
  • XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
  • LZAXPYOBKSJSEX-UHFFFAOYSA-N blebbistatin Chemical compound C1CC2(O)C(=O)C3=CC(C)=CC=C3N=C2N1C1=CC=CC=C1 LZAXPYOBKSJSEX-UHFFFAOYSA-N 0.000 description 5
  • 239000003153 chemical reaction reagent Substances 0.000 description 5
  • 210000002592 gangliocyte Anatomy 0.000 description 5
  • 238000010166 immunofluorescence Methods 0.000 description 5
  • 238000011160 research Methods 0.000 description 5
  • 210000000130 stem cell Anatomy 0.000 description 5
  • 230000009466 transformation Effects 0.000 description 5
  • 238000011282 treatment Methods 0.000 description 5
  • 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
  • 201000010099 disease Diseases 0.000 description 4
  • 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
  • 238000005516 engineering process Methods 0.000 description 4
  • 230000004438 eyesight Effects 0.000 description 4
  • 239000001963 growth medium Substances 0.000 description 4
  • 239000000463 material Substances 0.000 description 4
  • 230000008569 process Effects 0.000 description 4
  • 241001465754 Metazoa Species 0.000 description 3
  • 230000008901 benefit Effects 0.000 description 3
  • 230000006378 damage Effects 0.000 description 3
  • 238000011534 incubation Methods 0.000 description 3
  • 239000000047 product Substances 0.000 description 3
  • 238000004114 suspension culture Methods 0.000 description 3
  • FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
  • 101100272733 Gallus gallus BRN3 gene Proteins 0.000 description 2
  • 101000854931 Homo sapiens Visual system homeobox 2 Proteins 0.000 description 2
  • 208000035719 Maculopathy Diseases 0.000 description 2
  • 108010032788 PAX6 Transcription Factor Proteins 0.000 description 2
  • 102100037506 Paired box protein Pax-6 Human genes 0.000 description 2
  • 108091005804 Peptidases Proteins 0.000 description 2
  • 101150008375 Pou4f1 gene Proteins 0.000 description 2
  • 239000004365 Protease Substances 0.000 description 2
  • 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
  • 102100020676 Visual system homeobox 2 Human genes 0.000 description 2
  • FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
  • 208000027418 Wounds and injury Diseases 0.000 description 2
  • 238000007792 addition Methods 0.000 description 2
  • 230000001464 adherent effect Effects 0.000 description 2
  • FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
  • 230000001857 anti-mycotic effect Effects 0.000 description 2
  • 239000002543 antimycotic Substances 0.000 description 2
  • 230000003115 biocidal effect Effects 0.000 description 2
  • 239000006285 cell suspension Substances 0.000 description 2
  • 238000005119 centrifugation Methods 0.000 description 2
  • 230000008859 change Effects 0.000 description 2
  • 238000010586 diagram Methods 0.000 description 2
  • 238000004043 dyeing Methods 0.000 description 2
  • 239000000835 fiber Substances 0.000 description 2
  • 238000000338 in vitro Methods 0.000 description 2
  • 208000014674 injury Diseases 0.000 description 2
  • 208000002780 macular degeneration Diseases 0.000 description 2
  • 238000012423 maintenance Methods 0.000 description 2
  • 230000035800 maturation Effects 0.000 description 2
  • 210000005036 nerve Anatomy 0.000 description 2
  • 208000015122 neurodegenerative disease Diseases 0.000 description 2
  • 230000003287 optical effect Effects 0.000 description 2
  • 210000001778 pluripotent stem cell Anatomy 0.000 description 2
  • 230000004491 retinal development Effects 0.000 description 2
  • 150000003384 small molecules Chemical class 0.000 description 2
  • 230000009897 systematic effect Effects 0.000 description 2
  • 229960003080 taurine Drugs 0.000 description 2
  • WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
  • 229910052721 tungsten Inorganic materials 0.000 description 2
  • 239000010937 tungsten Substances 0.000 description 2
  • 235000019155 vitamin A Nutrition 0.000 description 2
  • 239000011719 vitamin A Substances 0.000 description 2
  • 229940045997 vitamin a Drugs 0.000 description 2
  • 206010000234 Abortion spontaneous Diseases 0.000 description 1
  • HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
  • 201000004569 Blindness Diseases 0.000 description 1
  • HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
  • 241001062009 Indigofera Species 0.000 description 1
  • 239000012580 N-2 Supplement Substances 0.000 description 1
  • 241001597008 Nomeidae Species 0.000 description 1
  • 208000017442 Retinal disease Diseases 0.000 description 1
  • 239000002253 acid Substances 0.000 description 1
  • 238000000889 atomisation Methods 0.000 description 1
  • 230000009286 beneficial effect Effects 0.000 description 1
  • 230000015572 biosynthetic process Effects 0.000 description 1
  • 230000024245 cell differentiation Effects 0.000 description 1
  • 230000004663 cell proliferation Effects 0.000 description 1
  • 210000003986 cell retinal photoreceptor Anatomy 0.000 description 1
  • 238000002659 cell therapy Methods 0.000 description 1
  • 239000012141 concentrate Substances 0.000 description 1
  • 239000000470 constituent Substances 0.000 description 1
  • 238000011109 contamination Methods 0.000 description 1
  • 238000012258 culturing Methods 0.000 description 1
  • 230000007850 degeneration Effects 0.000 description 1
  • 239000003814 drug Substances 0.000 description 1
  • 230000013020 embryo development Effects 0.000 description 1
  • 208000030533 eye disease Diseases 0.000 description 1
  • 230000004578 fetal growth Effects 0.000 description 1
  • 238000007667 floating Methods 0.000 description 1
  • 230000012010 growth Effects 0.000 description 1
  • 229960002897 heparin Drugs 0.000 description 1
  • 229920000669 heparin Polymers 0.000 description 1
  • 230000006872 improvement Effects 0.000 description 1
  • 238000001727 in vivo Methods 0.000 description 1
  • 239000000411 inducer Substances 0.000 description 1
  • 230000002427 irreversible effect Effects 0.000 description 1
  • 210000001161 mammalian embryo Anatomy 0.000 description 1
  • 238000004519 manufacturing process Methods 0.000 description 1
  • 239000003550 marker Substances 0.000 description 1
  • 230000007246 mechanism Effects 0.000 description 1
  • 210000004379 membrane Anatomy 0.000 description 1
  • 208000015994 miscarriage Diseases 0.000 description 1
  • 210000002569 neuron Anatomy 0.000 description 1
  • 230000004297 night vision Effects 0.000 description 1
  • 230000008520 organization Effects 0.000 description 1
  • 230000002093 peripheral effect Effects 0.000 description 1
  • 230000004310 photopic vision Effects 0.000 description 1
  • 239000002243 precursor Substances 0.000 description 1
  • 210000003370 receptor cell Anatomy 0.000 description 1
  • 230000001172 regenerating effect Effects 0.000 description 1
  • 230000011664 signaling Effects 0.000 description 1
  • 208000000995 spontaneous abortion Diseases 0.000 description 1
  • 238000009168 stem cell therapy Methods 0.000 description 1
  • 238000009580 stem-cell therapy Methods 0.000 description 1
  • 239000013589 supplement Substances 0.000 description 1
  • 239000000725 suspension Substances 0.000 description 1
  • 238000002560 therapeutic procedure Methods 0.000 description 1
  • 210000002700 urine Anatomy 0.000 description 1
  • 238000002255 vaccination Methods 0.000 description 1
  • 150000002266 vitamin A derivatives Chemical class 0.000 description 1
  • 230000003442 weekly effect Effects 0.000 description 1

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0621Eye cells, e.g. cornea, iris pigmented cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of methods obtaining the class retinal tissue rich in the cone and rod cell using people's induced multi-potent stem cell.It includes digesting hiPSCs to obtain cell precipitation, then cell precipitation is suspended to cultivate and obtains embryoid body;Embryoid body is inoculated to in the coated culture dishes of Matrigel, the induction differentiation in induction broth obtains neural retina (NR) and RPE in advance;NR and RPE are provoked again, suspend culture, it includes NR tissues to obtain 3D class retinas, then continue the culture that suspends in the optimization culture liquid of not retinoic acid, NR differentiates all retina cells, includes the photoreceptor cell of high mature, Rhodopsin positive rod cells, the positive red green cone cells of L/M OPSIN and the positive blue cone cells of S-OPSIN, especially obtain the class retinal tissue rich in the red green cone and rod cell.

Description

It is a kind of to be regarded using class of people's induced multi-potent stem cell acquisition rich in the cone and rod cell The method of omental organization

Technical field:

The invention belongs to stem cell regenerating biological fields, and in particular to multipotential stem cell regenerates class retina organ, obtains The method of retina seed cell.

Background technology

Retina degenerative disease is the main eye disease for causing irreversibility to be blinded, mainly due to photoreceptor cell, RPE Cell or gangliocyte are by irreversible damage.However, such disease there is no effective therapy at present.Stem-cell therapy New hope of recovering lost eyesight is brought for such disease, acquisition is similar with human retina cell characteristics, and the kind of quantity abundance is careful Born of the same parents are the key that retina degenerative disease is recovered lost eyesight treatment and disease mechanisms research.

Human retina cell was mostly detached from the Embryonic Retina of miscarriage and was obtained in the past, but quantity is very limited, batch matter Amount etc. is difficult to control, and be cannot be satisfied the needs of clinical treatment, is limited the development of retina cell's treatment technology.In recent years, people Retina cell can also include that embryo is dry thin from human pluripotent stem cells (human pluripotent stem cell, hPSC) Born of the same parents (ESC) and induced multi-potent stem cell (iPSC) Induction of committed differentiation, for retina seed cell provide it is new come Source.Currently, there are many induction differentiation schemes, and hPSC to be instructed gradually to break up to retina cell.First, it is adherent (i.e. in classics Two dimension, 2D) under condition of culture, hPSC has not only differentiated a variety of retina cells, including gangliocyte, RPE cells and Photoreceptor cell etc., can also directly induce original optic vesicle spline structure, and the latter further differentiates a variety of retina cells; Second, with the development of 3D suspended tissues Fiber differentiation system, 3D retina method for inducing and cultivating is born.Japanese Scientists profit With the method for suspension EBs, 3D optic vesicles are obtained from the ESC of mouse and people differentiation respectively, the latter further differentiates various developments In retina cell;Third, China scientist professor Zhong Xiufeng use the inducing culturing condition that 2D is combined with 3D, develop A set of retina induces differentiated system, and first hiPSCs suspends and cultivates, and obtains embryoid body EBs, then by EBs again adherent differentiation, The 3D class retinal tissues with layered structure, including all main retina cells are obtained, can be obtained after long-term cultivation Has functional photoreceptor cell.

Although the technology of multipotential stem cell induced retinal makes great progress, current retina induces differentiation scheme It comes with some shortcomings.First, most induction schemes are more complex, need to add various cell factors or signaling molecule, including regard Huang Sour A (retinoic acid, RA);Second, the retinal light injury photoreceptor obtained is based on rod cell, and cone cell is very It is few.Cone cell is responsible for daylight vision or photopic vision, color and crack vision, concentrates on the macular region of retina.Retinal rod is thin Born of the same parents are responsible for night vision or noctovision, are distributed in the peripheral portion of retina.The mankind mainly in activity on daytime, therefore, depend on The function of cone cell.Age associated retinal maculopathy has become the main diseases causing blindness of 50 years old global or more crowd, main It will be caused by cone cell degeneration death.Therefore, current retina induction scheme is difficult to meet needed for clinical treatment.

Invention content:

For existing retina induction differentiation technique there are the problem of (complicated component, it is difficult to obtain retinal disease treatment Required cone cell), the present invention provides a kind of class of improvement, the simple, effective acquisition rich in retinal rod and cone cell The induction scheme of retina.

The side that the class retinal tissue rich in the cone and rod cell is obtained using people's induced multi-potent stem cell of the present invention Method, including hiPSCs Clone Digestions are obtained into cell precipitation, then cell precipitation is suspended to cultivate and obtains embryoid body;Embryoid body is again It is seeded in advance in the coated culture dishes of Matrigel, differentiation is induced in induction broth, obtains neural retina (neural retina, NR) and RPE;NR and RPE are provoked again, suspend culture, obtain 3D class retinas include NR tissue and RPE.Using the culture solution long-term suspension culture without RA, NR can not only develop all retina cells, including height Ripe photoreceptor cell, Rhodopsin positive rod cells, the positive red green cone cells of L/M OPSIN and S-OPSIN sun Property indigo plant bore cell, be especially that of obtaining NR or class retinal tissue rich in retinal rod and red green cone cell.

First purpose of the present invention provides a kind of method of digestion hiPSCs clones, it is characterised in that preferably, described The cell precipitation that obtains hiPSCs Clone Digestions be to clone hiPSCs to be digested with EDTA to obtain cell precipitation.With dispase Digestion is compared, and EDTA digestion has the following advantages that:1) with EDTA digestion hiPSCs clone can gently blow and beat be dispersed into it is small Piece, and be mostly small agglomerate with the postdigestive products of dispase, so that the size and homogeneity to the formation of later stage EBs cause It influences;2) the hiPSCs cells of identical quantity while with EDTA and dispase are digested, the EBs quantity obtained after EDTA digestion is remote The EBs amounts obtained much larger than dispase digestion;3) EDTA is chemical reagent, non-animal source source, convenient for clinical Transformation Application; And dispase is protease, and it is variant between batch, it is animal sources source, is unfavorable for clinical Transformation Application;4) when EDTA digests Between it is short, at a temperature of digestion at 37 degree, about 3-6min is activity stabilized controllable;And dispase digestions time are long, activity is unstable, At a temperature of digestion at 37 degree, 10-20min, bad grasp condition, poor repeatability are needed.

It is preferred that it is with 0.5 μM of EDTA, 37 DEG C of digestion 5min that the EDTA, which digests,.

Second object of the present invention is efficiently simply differentiated from hiPSCs inductions rich in largely regarding there is provided a kind of The method for boring the 3D retinas of cell and rod cell comprising obtain 3D retinal tissues, then 3D retinal tissues exist It is cultivated in culture solution, which is characterized in that be to carry out 3D retinal tissues in the optimization culture liquid without containing retinoic acid Culture.3D retinal tissues after long-term cultivation develop ripe photoreceptor cell, and there are about 43% 3D class retina groups It knits rich in the positive red green cone cells of L/M OPSIN, is reported far above previous research.

By postdigestive hiPSCs cells, suspension culture is carried out by the way that 10mM Blebbistatin are added, generates embryoid body (EBs), it inoculates to using in the coated culture dishes of Matrigel in advance, carries out retina induction differentiation with culture solution, differentiate Retina and RPE provoked with Tungsten needles and carry out suspension culture, clear layer is obtained after long-term cultivation, rich in ripe light The 3D retinal tissues of receptor cell.According to induction atomization culture medium successively be mTeSR1, NIM culture solution, RDM culture solutions, RC2 culture solutions, RC1 culture solutions, mTeSR1 are that hiPSCs maintains culture solution, NIM culture solutions to be lured for early stage nerve Culture solution is led, RDM culture solutions are retina induction broth, and RC2 culture solutions and RC1 culture solutions are 3D retinal tissue cultures Liquid.The RC2 culture solutions and RC1 culture solutions is RC2/RA culture solutions, the RC1/RA culture solutions for not adding retinoic acid.Do not add On the one hand induction that retinoic acid reduces exogenous molecules is added to influence, on the other hand having saved the cost of culture medium, (every other day plus RA is changed New culture solution loss mass propgation liquid).In addition, retinoic acid is the signal of interest molecule of retinal photoreceptor Development And Differentiation, Previous studies show that the RA of high concentration inhibits reaching maturity for cone cell.The culture of retinoic acid is not added in the present invention Base promotes reaching maturity for photoreceptor cell, has especially induced more red green cone cells, has been expected to as people's view The cell therapy of film maculopathy provides required seed cell.

It is that 3D retinal tissues successively exist that the 3D retinal tissues carry out culture in the culture solution without containing RA It is cultivated in RC2 culture solutions and RC1 culture solutions, the RC2 culture solutions and RC1 culture solutions are referred respectively to without RA (depending on Huang Acid) RC2/RA culture solutions, RC1/RA culture solutions.

Beneficial effects of the present invention are as follows:

With EDTA digest hiPSCs come start differentiation and prepare EB advantage it is as follows:1) with hiPSCs grams of EDTA digestion Grand can gently blow and beat is dispersed into small pieces, and is mostly small agglomerate with the postdigestive products of dispase, so as to later stage EBs shape At size and homogeneity impact;2) the hiPSCs cells of identical quantity while with EDTA and dispase are digested, The EBs quantity obtained after EDTA digestion is far longer than the EBs amounts that dispase digestion obtains;3) EDTA is chemical reagent, non-dynamic Material resource source, convenient for clinical Transformation Application;And dispase is protease, and it is variant between batch, it is animal sources source, is unfavorable for Clinical Transformation Application;4) EDTA digestions time are short, and at a temperature of digestion at 37 degree, about 3-6min is activity stabilized controllable;And Dispase digestions time are long, and activity is unstable, at a temperature of digestion at 37 degree, 10-20min, bad grasp condition needed to repeat Property is poor.

RA is a kind of fat-soluble small molecule, is the metabolite of vitamin A (VitaminA), in embryo development procedure Have great importance.In eye growth course, RA forms optic rudiment, and cell Proliferation and differentiation play an important roll.Except this Except, research in vivo and in vitro has been found that RA has important adjustment effect to the development of photoreceptor cell.Based on above-mentioned reason By to promote photoreceptor cell to reach maturity, with ESC or iPSCs to the induction scheme of photoreceptor differentiation, culture medium All more or less adds RA as derivant, as a result, the photoreceptor cell induced in such systems with Based on rod cell, cone cell is seldom.

The 3D retina Differentiation Systems of the present invention dexterously solve the problems, such as this, not only obtain the class rich in rod cell Retinal tissue also obtains the retinal tissue rich in red green cone cell for the first time.Compared with other induction differentiation schemes, New departure of the present invention does not add small molecule inducer RA, in the culture of the system during retinal tissue long-term cultivation In the process, 3D retinas still physically well develop, and layered structure, early development is kept to go out main gangliocyte and centre god Through member, ripe photoreceptor cell is developed in the later stage, and there are the 3D retinal tissues of about half thin rich in the red green cone Born of the same parents.Innovatively propose new viewpoint, RA is in vitro in retinal light injury photoreceptor maturation process during fetal growth, it is not necessary to add Ingredient, in the induced environment for lacking RA, 3D retinal developments go out the tissue rich in red green cone cell.The advantage of the invention It is 1) to obtain the retinal tissue for being largely rich in cone cell;2) it reduces foreign constituents RA to be added, promotes the clinic of inducible system Transformation Application;3) culture medium cost and labour costs are saved, pollution risk is reduced.In previous research, extremely not due to RA Stablize, need frequent (what is had is daily) supplement and replace culture solution, have lost mass propgation liquid, a large amount of manpowers is needed to remain thin Born of the same parents, and increase the risk of cell contamination.

Description of the drawings:

Fig. 1 is EDTA and digestion initial stages and EB total amount comparison diagram of the dispase to hiPSCs:Scheme the hiPSCs of A equal parts Respectively with the cell precipitation for obtaining similar amount after EDTA (left figure) and dispase (right figure) digestion;Figure B uses EDTA respectively The postdigestive hiPSCs of (left figure) and dispase (right figure) carries out EB preparations, after EB centrifugations in the 6th day, EDTA digestion The EB precipitations (left figure) that hiPSCs is obtained are bigger than the EB precipitations (right figure) that the hiPSCs that EDTA digests is obtained.

Fig. 2 is the influence diagram for comparing EDTA and being formed to EB with dispase digestion process:It is to use respectively to scheme A, figure B and figure C The EB forms and quantity of D0, D3 and D6 after EDTA digestion;It is D0, D3 and D6 after being digested with dispase respectively to scheme D, figure E and figure F EB forms and quantity, EDTA digestion gained EB forms are relatively more uniform, and quantity is more.

Fig. 3, which is no RA optimizations inducible system, does not influence the differentiation of 3D retina early and middle portions:Scheme A and figure B shows 3D views Film (w6) early expression retinal precursor cells marker PAX6 and VSX2, figure C show that early stage 3D retina (w6) develops The gangliocyte of the BRN3 positives, figure D show that mid-term 3D retinas (w13) develop the amakrine of the AP2 positives.

Fig. 4 is the class retinal tissue (after differentiation 34 weeks) of no RA optimizations Fiber differentiation system long-term cultivation.It is low power to scheme A Figure;Figure B is the partial enlarged view of figure A, shows the acromere of hairbrush shape.

Fig. 5 is that immunofluorescence shows that the part class retinal tissue of no RA systematic cultivations is rich in Rhodopsin positive retinal rods Cell (w21).

Fig. 6 is that immunofluorescence shows that the part class retinal tissue of no RA systematic cultivations is rich in red green cone cell:Scheme A Showed by immune group result 3D retinal tissues are rich in the red green cone cell of a large amount of L/M OPSIN positives, and figure B is figure A whites The enlarged drawing of box, the rod cell that the Rhodopsin positives in A same class retinal tissues are schemed in figure C displays are reduced, and figure D is Scheme the enlarged drawing of C white box.

Fig. 7 is that immunofluorescence shows that the class retinal tissue of no RA optimization systems culture contains a small amount of S-OPSIN positives Blue cone cell (w21).

Specific implementation mode:

The following examples are further illustrations of the invention, rather than limiting the invention.

Embodiment 1:

One, the maintenance culture of hiPSCs

1, hiPSCs cells:Mankind's induced multi-potent stem cell in urine source, cell line UE017

2, reagent and consumptive material:

1) mTeSR1 culture mediums:STEM CELL, #05851,4 DEG C

2)EDTA:Invitrogen, 15575-038, room temperature

3) dispase, sigma, D4693, room temperature

4)PBS(1X):Ji Nuo biological medicine technologies Co., Ltd, 14111202, room temperature

5)Matrigel:Corning, 354277, -20 DEG C

6) six orifice plate:FALCON, 353046

7) centrifuge tube:BD FALCON, 352096

3, instrument

1)CO2Incubator:SANYO, MCO-20A1C

2) inverted microscope:Nikon, TS100

4, step:

HiPSCs maintenances are incubated in mTeSR1 culture mediums, are passed on when density is grown to about 80%-90% floor spaces (about 4-5 days), are digested with the dispase of the EDTA of 0.5mM or 1mg/mL, and postdigestive cell kind is in Matrigel packets On the culture plate of quilt.

Two, the influence that the digestion method of hiPSCs forms embryoid body (EBs)

1, cell:The hiPSCs cells of step 1 culture

2, reagent and consumptive material:

1) mTeSR1 culture mediums:STEM CELL, #05851,4 DEG C

2) NIM culture mediums (formula is shown in Table 1, and preparation method is to be uniformly mixed each ingredient by its content)

3)EDTA:0.5M EDTA solution, Invitrogen, 15575-038, room temperature

4) dispase, sigma, D4693, room temperature

5)Blebbistatin:sigma

6)Matrigel:Corning, 354277, -20 DEG C

7) low adsorption ware (100mm):

3, instrument:

1)CO2Incubator:SANYO, MCO-20A1C

4, step:

EB is prepared with EDTA digestion hiPSCs:It is differentiated thin during the hiPSCs of step 1 is cloned under an optical microscope Born of the same parents strike off, remaining to suck culture solution, are cleaned one time with sterile PBS, and 0.5mM EDTA are added, and 37 DEG C of incubation 5min use pipette tips It gently blows and beats 3-5 time or so, collects cell suspension, 1000rpm, centrifugation 4min, cell precipitation is with containing 10 μM The culture solution of Blebbistatin is resuspended, 37 DEG C of cultures that suspend, overnight.

EB is prepared with dispase digestion hiPSCs:It first under an optical microscope will be differentiated in the hiPSCs of step 1 Cell strikes off, remaining to suck culture solution, is cleaned one time with sterile PBS, and the dispase of 1mg/ml, 37 DEG C of incubations are added 15min is gently blown and beaten 5 times or so with pipette tips, collects cell suspension, and 1000rpm centrifuges 4min, and cell precipitation, which is used, contains 10 μM Blebbistatin culture solution be resuspended, 37 DEG C suspend culture, overnight.

The EDTA or dispase cell precipitations digested are resuspended in the culture solution containing 10 μM of Blebbistatin respectively In, it is transferred to low adsorption ware, 37 DEG C of overnight incubations, EBs prepares the same day and is labeled as the 0th day, and next day is denoted as the 1st day, the 1st day, Culture solution replaces with volume fraction 25%NIM (formula is shown in Table 1)+volume fraction 75%mTeSR1;2nd day, culture solution replaced with Volume fraction 50%NIM+ volume fraction 50%mTeSR1 all change NIM culture solution cultures into since third day, continuous outstanding Floating culture was to the 6-7 days.Visible EBs is formed within second day, continuous to keep culture 6-7 days that suspends, and is centrifuged respectively, and observation precipitation is big Small (Fig. 1).

As shown in Figure 1, the hiPSCs of identical quantity uses EDTA or dispase to digest respectively, Fig. 1-A show two kinds of sides The postdigestive cell precipitation of method is almost the same;Fig. 1-B displays, the EB precipitations after suspending 6 days, the EBs amounts that EDTA digestion obtains are bright It is aobvious to be digested higher than dispse.

Fig. 2 is the influence for comparing EDTA and being formed to EB with dispase digestion process, as shown in Fig. 2, identical quantity HiPSCs uses EDTA or dispase to digest respectively, and Fig. 2-A and Fig. 2-D show the thin of the EDTA and dispase digestion same day respectively Born of the same parents' agglomerate size and number, the postdigestive cells of EDTA relatively disperse it is uniform, and the digestion product of dispase some be in strip, Same day observation cell quantity does not have notable difference;Fig. 2-B and Fig. 2-E are respectively the EBs after assembling 3 days, and EDTA digestion obtains EBs quantity is significantly more than dispase;Fig. 2-C and Fig. 2-F are respectively the EBs after 6 days, and it is apparent that EDTA digestion obtains EBs quantity More than dispase.

Three, 3D retinas break up and are formulated induction photoreceptor maturation without RA

1, cell:hiPSCs(UE017)

2, reagent and consumptive material:

1) RDM culture solutions:Formula is shown in Table 2, and preparation method is to be uniformly mixed each ingredient by its content;

2) RC2 culture solutions:Formula is shown in Table 3, and preparation method is to be uniformly mixed each ingredient by its content;

3)RC1-Culture solution:Formula is shown in Table 4, and preparation method is to be uniformly mixed each ingredient by its content;

4) 24 orifice plate of low adsorption or low adsorption ware:BIOFIL, 170313-076

3, instrument:

1)CO2Incubator:SANYO, MCO-20A1C

4, step:

HiPSCs is digested with above-mentioned EDTA schemes, and the culture that suspends obtains EBs.The digestion same day is labeled as the 0th day (D0), Next day is denoted as the 1st day, and so on.6th or 7 day, by EBs renewed vaccinations in using the coated culture dishes of Matrigel in advance, Start adhere-wall culture induction differentiation.Breaking up 4th week, the regions NR and RPE preliminarily form, can be recognized under inverted microscope, and It is provoked in tungsten filament, is moved into 24 orifice plates or low adsorption ware of low adsorption the culture that suspends, changes liquid weekly 2-3 times.Suspend culture Under the conditions of, NR developments thicken, and gradually form translucent ring-type, the subsidiary more or less RPE in one end, referred to as " 3D class retinas Tissue ", and can continue to break up with long-term cultivation, NR, Development And Differentiation goes out all retinal neuronal cells, including photoreceptor Cell.Culture solution scheme (bibliography Xiufeng Zhong, Nature Communications similar with having published an article 2014), in addition to being not added with any RA, specially:The 6-15 days, nerve-inducing is carried out using NIM (table 1), is used within the 16-41 days RDM culture solutions (table 2), from the 42-90 days, 3D retinas were cultivated with the RC2 culture solutions (table 3) that FBS is added, from the 91st It starts to carry out longer-term culture with RC1 culture solutions (table 4).

RA is typically considered to have the function of that retinal development and photoreceptor cell are ripe, former scheme (existing skill Scheme in art, table 5RC2/RA culture solutions and table 6RC1/RA culture solutions, bibliography Xiufeng Zhong, Nature Communications 2014) in addition RA induced, from the 42-90 days or the 63-90 days, with containing 1 μM of RA RC2 culture solutions were daily or change liquid (table 5, preparation method are to be uniformly mixed each ingredient by its content) every other day, from 91 days More than, changing the RC1 culture solutions containing 0.5 μM of RA every other day, (table 6, preparation method are to be uniformly mixed each ingredient by its content ), the differentiation of induction 3D retinas and photoreceptor are ripe.

And in the present invention, 3D retinal tissues still select to use RC2 and RC1 culture solutions respectively at above-mentioned two time point Culture, but RA inductions are added without, the formula of specific culture solution is as shown in Table 3 and Table 4.Every batch of chooses 3-5 3D retina of early stage Tissue, it is fixed, it is dehydrated, slice carries out immunofluorescence dyeing identification.As a result illustrate, the 3D retinas in the inducible system of no RA Development is not affected by influence, and equally follows the development course of retina.From figure 3, it can be seen that in the solution of the present invention, HiPSCs equally follows the development course of retina, the 3D view film expression early stage neural retina markers at the initial stage that suspends PAX6 and VSX2 (Fig. 3-A and 3-B), development mid-term generate BRN3 positive gangliocyte (Fig. 3-C) and AP2 the positive Amakrine (Fig. 3-D).

By being up to the culture of 17 weeks or more (longest 34 weeks), it is thin that 3D retinal tissues differentiate ripe photoreceptor Born of the same parents.As can be seen that Fig. 4-A are in RC2 and RC1 culture mediums in Fig. 4, the 3D retinas of long-term cultivation are carried out, about 34w is regarded Nethike embrane;Fig. 4-B show that the retinal tissue contains a large amount of outer section structures.The 3D retinal tissues of long-term cultivation, every batch of choose 3- It is 5, fixed, it is dehydrated, slice carries out immunofluorescence dyeing identification (general technology).As a result, it has been found that Differentiation System production of the present invention About 50% 3D retinal tissues are (7/14, n=based on the rod cell of the Rhodopsin positives in raw retinal tissue 14), Fig. 5 is shown in the optimization culture environment of no RA additions, and the retinal rod that 3D retinas contain a large amount of Rhodopsin positives is thin Born of the same parents.Importantly, there are about the red green cone cells (6/ that 43% 3D retinal tissues contain a large amount of L/M OPSIN positives 14, n=14), Fig. 6-A add for no RA in environment, and 3D retinas contain the cone cell of a large amount of L/M OPSIN positives, Fig. 6- B is the enlarged drawing in the white box of left side, and Fig. 6-C show that the rod cell ratio of the Rhodopsin positives in the tissue is reduced, Fig. 6-D are the enlarged drawing in the white box of left side.Fig. 7 is shown in the culture environment of no RA additions, and 3D retinas contain a small amount of S The blue cones cell of the opsin positives.And the 3D retinal tissues that prior art systems obtain, 90% or more is Rhodopsin sun Property rod cell, the red green cone cell of a small amount of L/M OPSIN positives and a small amount of S-OPSIN positive blue cone cell.Therefore, Compared with prior art, present system can obtain the view of the red green cone cell more containing the L/M OPSIN positives Membrane tissue, and the blue cones cell proportion of the S-OPSIN positives is still smaller, it is almost the same with research before.

Table 1NIM culture solutions (the 3-15 days)

Ingredient Amount(ml) Final concentration
DMEM/F12(1:1)(Gibco,C11330500BT) 500.00
100×N2(Gibco,17502-048) 5.00 1x
Heparin(2mg/ml in PBS,) 0.50 2ug/ml
100×MEM-NEAA(Gibco,11140-050) 5.00 1x
510.50

Table 2RDM culture solutions (the 16-41 days)

Table 3RC2 culture solutions (the 42-90 days) (present invention)

Ingredient Amount(ml) Final concentration
DMEM/F12(1:1)(Gibco,C11330500BT) 250.00
DMEM basic(Gibco,C11995500BT) 175.00
50×B27 without vitamin A(Gibco,12587-010) 10.00 1x
100×antibiotic and antimycotic(Gibco,15240) 5.00 1x
100×MEM-NEAA(Gibco,11140-050) 5.00 1x
FBS(Gibco,10099-141) 50.00 10%
100×GlutaMax(Gibco,35050-061) 5.00
1000×Taurine(sigma,#T-0625) 0.50 100μM
500.50

Table 4RC1 culture solutions (after the 91st day) (present invention)

Ingredient Amount(ml) Final concentration
DMEM/F12-Glutamax(Gibco,C10565-018) 450.00
100×N2 supplement(Invitrogen,17502-048) 5.00 1x
100×antibiotic and antimycotic(Gibco,15240) 5.00 1x
100×MEM-NEAA(Gibco,11140-050) 5.00 1x
FBS(Gibco,10099-141) 50.00 10%
1000×Taurine(sigma,#T-0625) 0.50 100μM
515.50

Table 5RC2/RA culture solutions (the 42-90 days) (old scheme)

Table 6RC1/RA culture solutions (after the 91st day) (old scheme)

Claims (5)

1. a kind of method obtaining the class retinal tissue rich in the cone and rod cell using people's induced multi-potent stem cell, special Sign is, including digests to obtain cell precipitation by hiPSCs, then the cell precipitation culture that suspends is obtained embryoid body;Embryoid body connects again Kind to in the coated culture dishes of Matrigel, differentiation is induced in induction broth in advance, obtain neural retina (NR) and Retinal pigment epithelium (RPE);NR and RPE are provoked again, suspend culture, obtain 3D class retinas include NR tissue and RPE, It does not add and continues the culture that suspends in the culture solution of retinoic acid, NR develops all retina cells, includes the light sensation of high mature Receiver cell, Rhodopsin positives rod cell and the positive red green cone cells of L/M OPSIN and S-OPSIN positive blue cones Cell especially obtains the retinal tissue rich in red green cone cell and rod cell.

2. according to the method described in claim 1, it is characterized in that, it is described by hiPSCs digest to obtain cell precipitation be by HiPSCs clones are digested to obtain cell precipitation with EDTA.

3. according to the method described in claim 2, it is characterized in that, described with EDTA digestion is 37 DEG C with 0.5 μM of EDTA Digest 5min.

4. a kind of efficiently simply differentiating the 3D retinas rich in a large amount of cone cells and rod cell from hiPSCs inductions Method comprising obtain 3D retinal tissues, then cultivate 3D retinal tissues in culture solution, which is characterized in that It is to cultivate 3D retinal tissues in the culture solution without containing retinoic acid (RA).

5. according to the method described in claim 4, it is characterized in that, the 3D retinal tissues are in the culture solution without containing RA In to carry out culture be successively to cultivate 3D retinal tissues in RC2 culture solutions and RC1 culture solutions.

CN201810510145.4A 2018-05-24 2018-05-24 Method for obtaining retinal-like tissue rich in cones and rods by using human induced pluripotent stem cells Expired - Fee Related CN108795864B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810510145.4A CN108795864B (en) 2018-05-24 2018-05-24 Method for obtaining retinal-like tissue rich in cones and rods by using human induced pluripotent stem cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810510145.4A CN108795864B (en) 2018-05-24 2018-05-24 Method for obtaining retinal-like tissue rich in cones and rods by using human induced pluripotent stem cells

Publications (2)

Publication Number Publication Date
CN108795864A true CN108795864A (en) 2018-11-13
CN108795864B CN108795864B (en) 2021-08-24

Family

ID=64091777

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810510145.4A Expired - Fee Related CN108795864B (en) 2018-05-24 2018-05-24 Method for obtaining retinal-like tissue rich in cones and rods by using human induced pluripotent stem cells

Country Status (1)

Country Link
CN (1) CN108795864B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109423480A (en) * 2017-12-21 2019-03-05 中山大学中山眼科中心 A kind of mechanizable abductive approach of simple and efficient that human pluripotent stem cells are divided into retinal tissue
CN112175909A (en) * 2020-09-11 2021-01-05 中山大学中山眼科中心 VSX2 green fluorescent reporter gene human induced pluripotent stem cell line and construction method thereof
CN112175995A (en) * 2020-09-11 2021-01-05 中山大学中山眼科中心 VSX2 green fluorescent reporter gene vector system and construction method thereof
WO2022134031A1 (en) * 2020-12-25 2022-06-30 武汉睿健医药科技有限公司 Chemical induction method for photoreceptor neuron cells

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120258451A1 (en) * 2011-04-08 2012-10-11 Advanced Cell Technology, Inc. Laser isolation of viable cells
CN103627669A (en) * 2012-08-22 2014-03-12 复旦大学 Method used for inducing differentiation of human multipotential stem cells into retinal progenitor cells
CN105378070A (en) * 2013-03-15 2016-03-02 奥卡塔治疗公司 Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
CN105492596A (en) * 2013-04-26 2016-04-13 皮埃尔-玛丽-居里大学(巴黎第六大学) Methods for obtaining retinal progenitors, retinal pigmented epithelial cells and neural retinal cells
CN106047792A (en) * 2016-06-17 2016-10-26 中国人民解放军第三军医大学第附属医院 Method for culturing retinal pigment epithelium (RPE) cells in vitro
US20170321188A1 (en) * 2016-05-04 2017-11-09 The Research Foundation For The State University Of New York Methods of generating retinal progenitor cell preparations and uses thereof
CN107427534A (en) * 2014-12-30 2017-12-01 细胞治疗神经科学有限公司 The method for treating retinal disease
WO2018055131A1 (en) * 2016-09-22 2018-03-29 Universite Pierre Et Marie Curie (Paris 6) Optogenetically transformed photoreceptor precursor cells for the use in the treatment of retinal degenerative diseases
CN108728413A (en) * 2017-06-13 2018-11-02 中山大学中山眼科中心 A kind of preparation of human pluripotent stem cells source Human RPE Cells in Vitro and amplification cultivation method

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120258451A1 (en) * 2011-04-08 2012-10-11 Advanced Cell Technology, Inc. Laser isolation of viable cells
CN103627669A (en) * 2012-08-22 2014-03-12 复旦大学 Method used for inducing differentiation of human multipotential stem cells into retinal progenitor cells
CN105378070A (en) * 2013-03-15 2016-03-02 奥卡塔治疗公司 Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
CN105492596A (en) * 2013-04-26 2016-04-13 皮埃尔-玛丽-居里大学(巴黎第六大学) Methods for obtaining retinal progenitors, retinal pigmented epithelial cells and neural retinal cells
CN107427534A (en) * 2014-12-30 2017-12-01 细胞治疗神经科学有限公司 The method for treating retinal disease
US20170321188A1 (en) * 2016-05-04 2017-11-09 The Research Foundation For The State University Of New York Methods of generating retinal progenitor cell preparations and uses thereof
CN106047792A (en) * 2016-06-17 2016-10-26 中国人民解放军第三军医大学第附属医院 Method for culturing retinal pigment epithelium (RPE) cells in vitro
WO2018055131A1 (en) * 2016-09-22 2018-03-29 Universite Pierre Et Marie Curie (Paris 6) Optogenetically transformed photoreceptor precursor cells for the use in the treatment of retinal degenerative diseases
CN108728413A (en) * 2017-06-13 2018-11-02 中山大学中山眼科中心 A kind of preparation of human pluripotent stem cells source Human RPE Cells in Vitro and amplification cultivation method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HUAN YI等: "Derivation and Identification of Motor Neurons from Human Urine-Derived Induced Pluripotent Stem Cells", 《STEM CELLS INTERNATIONA》 *
XIUFENG ZHONG等: "Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs", 《NATURE COMMUNICATIONS》 *
孟凤熙等: "诱导多能干细胞分化为视网膜神经细胞和色素上皮细胞的研究现状", 《中华眼科杂志》 *
曹明哲等: "从胚胎干细胞到视网膜", 《中华细胞与干细胞杂志(电子版)》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109423480A (en) * 2017-12-21 2019-03-05 中山大学中山眼科中心 A kind of mechanizable abductive approach of simple and efficient that human pluripotent stem cells are divided into retinal tissue
CN112175909A (en) * 2020-09-11 2021-01-05 中山大学中山眼科中心 VSX2 green fluorescent reporter gene human induced pluripotent stem cell line and construction method thereof
CN112175995A (en) * 2020-09-11 2021-01-05 中山大学中山眼科中心 VSX2 green fluorescent reporter gene vector system and construction method thereof
CN112175995B (en) * 2020-09-11 2023-04-14 中山大学中山眼科中心 VSX2 green fluorescence reporter gene vector system and construction method thereof
CN112175909B (en) * 2020-09-11 2023-04-28 中山大学中山眼科中心 VSX2 green fluorescent reporter gene human-induced pluripotent stem cell line and construction method thereof
WO2022134031A1 (en) * 2020-12-25 2022-06-30 武汉睿健医药科技有限公司 Chemical induction method for photoreceptor neuron cells

Also Published As

Publication number Publication date
CN108795864B (en) 2021-08-24

Similar Documents

Publication Publication Date Title
CN108795864A (en) 2018-11-13 A method of obtaining the class retinal tissue rich in the cone and rod cell using people's induced multi-potent stem cell
CN103656742B (en) 2015-04-15 Preparation method of functionalized retinal pigment epithelial cell graft
CN104877964A (en) 2015-09-02 In vitro construction method for salivary glands organs and acinus
WO2018228071A1 (en) 2018-12-20 Preparation and amplification culture methods for human pluripotent stem-cell-derived human retinal pigment epithelial cell
CN104805054A (en) 2015-07-29 Serum-free medium of stem cell
CN110042082A (en) 2019-07-23 Retinal pigment epithelium and its preparation method and application
CN103013909B (en) 2014-11-19 A method for efficiently isolating avian embryonic stem cells
CN109749997A (en) 2019-05-14 A kind of Limbus corneae stem cell serum-free culture medium and its cultural method
JP2021525106A (en) 2021-09-24 Method for producing differentiation medium and oligodendrocyte progenitor cells
CN111088229B (en) 2021-08-24 Preparation method of retina precursor cells derived from human pluripotent stem cells
CN109266610A (en) 2019-01-25 A method of promotion Derived from Mesenchymal Stem Cells is neuron
CN108324993A (en) 2018-07-27 A kind of stem cell complex, preparation method and the application of induction hair regeneration
CN107164325B (en) 2019-09-17 The preparation method and kit of the oligodendroglia in the source MSCs
CN101597592B (en) 2011-12-28 Human corneal endothelial cell culture solution as well as preparation method and application thereof
CN103923876A (en) 2014-07-16 Single cell cloning culture method
CN108795842B (en) 2021-08-03 A method and application of 3D suspension inducing iPS cells to generate autologous melanocytes
CN102747029B (en) 2013-09-25 Culture method for retina progenitor cells and culture medium thereof
CN113528441A (en) 2021-10-22 Rapid and efficient clinical-grade pigment epithelial cell induction method, kit and application
CN106635955A (en) 2017-05-10 Obtaining method of analogous corneal endothelial cell
CN115747154A (en) 2023-03-07 A medium for long-term culture of fish muscle stem cells
CN105907717A (en) 2016-08-31 Primary mouse or rat neuron isolation and culture method
CN117286106A (en) 2023-12-26 Mouse retina organoid, terminally differentiated cell line, construction method and application thereof
CN106635990B (en) 2020-09-08 Method for primary culture of dorsal root ganglion satellite glial cells
CN107384862A (en) 2017-11-24 The preparation method and kit of the schwann cell in MSCs sources
CN112391337B (en) 2022-04-12 Separation and primary culture method of pigeon crop fibroblasts

Legal Events

Date Code Title Description
2018-11-13 PB01 Publication
2018-11-13 PB01 Publication
2018-12-07 SE01 Entry into force of request for substantive examination
2018-12-07 SE01 Entry into force of request for substantive examination
2021-08-24 GR01 Patent grant
2021-08-24 GR01 Patent grant
2024-05-31 CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210824

2024-05-31 CF01 Termination of patent right due to non-payment of annual fee